Ranked #1,498 of 8,699 institutional investors
ADAR1 Capital Management, LLC
Austin, TX
$2.04B
US stock portfolio at live prices · today −$25.8M (−1.25%)
Live prices, last trade 10:22 AM ET
- Value at quarter end (Q3 2026)
- $2.31B
- Change from Q2 2026
- +$196.3M (+9.29%)
- Positions
- 220 · 32 new, 24 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: call options on $16.0M of stock, put options on $741K, $23.9M of convertible notes and other principal-amount securities. $297M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesABVX 7.27%SPY 6.21%PTGX 5.70%ZLAB 3.47%IMVT 3.35%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| ABVX ABIVAX Société Anonyme | 2,050,822 | $148M | 7.27% | Added +14% |
| SPY State Street SPDR S&P 500 ETF Trust | 177,624 | $127M | 6.21% | Added +38% |
| PTGX Protagonist Therapeutics, Inc. | 951,403 | $116M | 5.70% | Reduced −1% |
| ZLAB Zai Lab Limited | 3,381,364 | $70.8M | 3.47% | Added +0% |
| IMVT Immunovant, Inc. | 2,115,502 | $68.3M | 3.35% | Reduced −9% |
| XENE Xenon Pharmaceuticals Inc. | 1,162,029 | $44.0M | 2.16% | Added +598% |
| BOXX Alpha Architect 1-3 Month Box ETF | 337,125 | $40.2M | 1.97% | Unchanged |
| DNLI Denali Therapeutics Inc. | 2,072,050 | $38.5M | 1.89% | Added +101% |
| SEPN Septerna, Inc. | 974,396 | $38.1M | 1.87% | Added +4% |
| AURA Aura Biosciences, Inc. | 5,385,879 | $37.4M | 1.83% | Added +4,038% |
| INSM Insmed Incorporated | 229,531 | $33.0M | 1.62% | Added +0% |
| AGIO Agios Pharmaceuticals, Inc. | 1,139,464 | $32.5M | 1.59% | Reduced −12% |
| BBIO BridgeBio Pharma, Inc. | 379,261 | $29.5M | 1.45% | Added +115% |
| VKTX Viking Therapeutics, Inc. | 1,034,749 | $26.5M | 1.30% | Added +80% |
| PRAX Praxis Precision Medicines, Inc. | 84,751 | $26.1M | 1.28% | Added +14% |
| FULC Fulcrum Therapeutics, Inc. | 6,648,027 | $24.7M | 1.21% | Added +325% |
| CYTK Cytokinetics, Incorporated | 461,407 | $24.4M | 1.19% | Added +1% |
| SYRE Spyre Therapeutics, Inc. | 237,567 | $23.0M | 1.13% | Reduced −16% |
| CLDX Celldex Therapeutics, Inc. | 799,304 | $22.0M | 1.08% | Added +29% |
| SNY Sanofi | 464,600 | $21.7M | 1.06% | Added +714% |
| ELVN Enliven Therapeutics, Inc. | 442,682 | $21.1M | 1.04% | Added +14% |
| MAZE Maze Therapeutics, Inc. | 637,353 | $20.7M | 1.01% | Added +88% |
| DBVT DBV Technologies S.A. | 2,010,831 | $19.0M | 0.93% | Added +281% |
| VIR Vir Biotechnology, Inc. | 2,158,839 | $18.9M | 0.93% | Reduced −12% |
| AVR Anteris Technologies Global Corp. | 3,237,321 | $16.5M | 0.81% | Added +3% |
| FRNM Freenome, Inc. | 1,645,800 | $15.9M | 0.78% | New |
| RYTM Rhythm Pharmaceuticals, Inc. | 138,658 | $15.9M | 0.78% | Added +2% |
| EDIT Editas Medicine, Inc. | 8,889,000 | $15.6M | 0.76% | Unchanged |
| REGN Regeneron Pharmaceuticals, Inc. | 16,446 | $15.4M | 0.76% | Reduced −26% |
| XNCR Xencor, Inc. | 433,807 | $14.8M | 0.73% | Added +87% |
| RVMD Revolution Medicines, Inc. | 87,509 | $14.5M | 0.71% | Unchanged |
| RLYB Rallybio Corporation | 926,352 | $14.2M | 0.70% | Unchanged |
| ENTA Enanta Pharmaceuticals, Inc. | 1,733,320 | $13.7M | 0.67% | Added +29% |
| SRPT Sarepta Therapeutics, Inc. | 952,063 | $13.5M | 0.66% | Added +30% |
| SLN Silence Therapeutics plc | 629,654 | $12.5M | 0.61% | Added +86% |
| MNPR Monopar Therapeutics Inc. | 179,032 | $12.4M | 0.61% | Reduced −18% |
| BIL State Street SPDR Bloomberg 1-3 Month T-Bill ETF | 135,585 | $12.4M | 0.61% | Unchanged |
| REPL Replimune Group, Inc. | 655,784 | $12.4M | 0.61% | Unchanged |
| TSHA Taysha Gene Therapies, Inc. | 3,059,567 | $11.4M | 0.56% | Added +1% |
| AVLN Avalyn Pharma Inc. | 397,719 | $11.4M | 0.56% | Added +172% |
| NRIX Nurix Therapeutics, Inc. | 813,236 | $11.0M | 0.54% | Added +160% |
| COGT Cogent Biosciences, Inc. | 392,422 | $10.7M | 0.53% | Added +3,117% |
| OVID Ovid Therapeutics Inc. | 4,560,813 | $10.4M | 0.51% | Reduced −39% |
| VOR Vor Biopharma Inc. | 531,349 | $10.2M | 0.50% | Reduced −22% |
| EWTX Edgewise Therapeutics, Inc. | 243,199 | $10.0M | 0.49% | Added +70% |
| AMLX Amylyx Pharmaceuticals, Inc. | 366,968 | $9.6M | 0.47% | Reduced −26% |
| BEAM Beam Therapeutics Inc. | 420,981 | $9.0M | 0.44% | New |
| GLUE Monte Rosa Therapeutics, Inc. | 1,007,752 | $8.9M | 0.44% | Added +365% |
| ANL Adlai Nortye Group Ltd. | 997,356 | $8.7M | 0.43% | Reduced −2% |
| TENX Tenax Therapeutics, Inc. | 6,524,151 | $8.6M | 0.42% | Added +2,859% |
| JANX Janux Therapeutics, Inc. | 823,876 | $8.6M | 0.42% | Added +96% |
| PCVX Vaxcyte, Inc. | 146,034 | $8.5M | 0.42% | Unchanged |
| ABCL AbCellera Biologics Inc. | 822,163 | $8.2M | 0.40% | New |
| NKTR Nektar Therapeutics | 258,182 | $7.9M | 0.39% | Added +6% |
| IKT Inhibikase Therapeutics, Inc. | 5,708,755 | $7.7M | 0.38% | Reduced −23% |
| CLYM Climb Bio Inc | 792,936 | $7.4M | 0.36% | Reduced −4% |
| IRD Opus Genetics, Inc. | 1,783,781 | $7.1M | 0.35% | Unchanged |
| IVA Inventiva S.A. | 2,066,330 | $7.0M | 0.34% | Reduced −43% |
| VOGX Vogenx, Inc. | 522,175 | $6.7M | 0.33% | New |
| KRRO Korro Bio, Inc. | 540,054 | $6.7M | 0.33% | Unchanged |
| SVRA Savara Inc. | 1,410,409 | $6.3M | 0.31% | Added +0% |
| BIIB Biogen Inc. | 24,400 | $6.2M | 0.30% | Added +36% |
| OKUR OnKure Therapeutics, Inc. | 2,238,684 | $6.1M | 0.30% | Unchanged |
| ALEC Alector, Inc. | 2,514,840 | $6.0M | 0.30% | Reduced −13% |
| PRME Prime Medicine, Inc. | 1,598,042 | $6.0M | 0.30% | Reduced −20% |
| ZNTL Zentalis Pharmaceuticals, Inc. | 3,762,532 | $5.5M | 0.27% | Added +476% |
| CCCC C4 Therapeutics, Inc. | 2,232,857 | $5.5M | 0.27% | Added +665% |
| PEPG PepGen Inc. | 1,440,874 | $5.5M | 0.27% | Reduced −44% |
| KRYS Krystal Biotech, Inc. | 16,420 | $5.3M | 0.26% | Unchanged |
| KZIA Kazia Therapeutics Limited | 967,740 | $5.2M | 0.26% | Added +1,472% |
| DXYZ Destiny Tech100 Inc. | 210,399 | $5.2M | 0.25% | New |
| SMMT Summit Therapeutics Inc. | 496,965 | $5.1M | 0.25% | Added +159% |
| RARE Ultragenyx Pharmaceutical Inc. | 300,000 | $5.0M | 0.25% | New |
| LXEO Lexeo Therapeutics, Inc. | 1,576,796 | $5.0M | 0.25% | Added +1% |
| NXTC NextCure, Inc. | 722,419 | $4.9M | 0.24% | New |
| CGON CG Oncology, Inc. | 59,332 | $4.9M | 0.24% | Reduced −50% |
| DHR Danaher Corporation | 21,132 | $4.8M | 0.23% | Reduced −19% |
| TARS Tarsus Pharmaceuticals, Inc. | 62,500 | $4.7M | 0.23% | New |
| CTMX CytomX Therapeutics, Inc. | 2,204,454 | $4.7M | 0.23% | Reduced −34% |
| IONS Ionis Pharmaceuticals, Inc. | 169,593 | $4.7M | 0.23% | Added +2% |
| ONC BeOne Medicines AG | 11,701 | $4.6M | 0.23% | Unchanged |
| MPLT MapLight Therapeutics, Inc. | 725,165 | $4.6M | 0.23% | Added +2,637% |
| PFE Pfizer Inc. | 162,400 | $4.6M | 0.22% | Reduced −36% |
| ARDX Ardelyx, Inc. | 1,492,000 | $4.5M | 0.22% | Added +13,464% |
| BOLD Boundless Bio, Inc. | 1,893,439 | $4.3M | 0.21% | Reduced −4% |
| DCTH Delcath Systems, Inc. | 224,385 | $4.3M | 0.21% | Unchanged |
| WHWK Whitehawk Therapeutics, Inc. | 1,341,394 | $4.1M | 0.20% | Unchanged |
| CAPR Capricor Therapeutics, Inc. | 526,996 | $4.0M | 0.20% | Added +482% |
| YARW Yarrow Bioscience, Inc. | 282,996 | $4.0M | 0.19% | New |
| INSP Inspire Medical Systems, Inc. | 70,029 | $3.9M | 0.19% | Reduced −81% |
| EQ Equillium, Inc. | 3,446,539 | $3.9M | 0.19% | Reduced −8% |
| ISRG Intuitive Surgical, Inc. | 9,230 | $3.8M | 0.18% | Added +53% |
| CTNM Contineum Therapeutics, Inc. | 384,890 | $3.5M | 0.17% | Added +38% |
| GMED Globus Medical, Inc. | 50,100 | $3.5M | 0.17% | Reduced −29% |
| RLAY Relay Therapeutics, Inc. | 212,500 | $3.4M | 0.17% | Reduced −41% |
| PLRX Pliant Therapeutics, Inc. | 5,509,724 | $3.3M | 0.16% | Unchanged |
| BCRX BioCryst Pharmaceuticals, Inc. | 447,105 | $3.3M | 0.16% | Added +236% |
| MLYS Mineralys Therapeutics, Inc. | 227,294 | $3.3M | 0.16% | Reduced −24% |
| PMVP PMV Pharmaceuticals, Inc. | 2,700,349 | $3.2M | 0.15% | Added +1,243% |
| BMRN BioMarin Pharmaceutical Inc. | 51,200 | $3.1M | 0.15% | Added +4% |
| ARWR Arrowhead Pharmaceuticals, Inc. | 69,200 | $3.0M | 0.15% | Reduced −1% |
| QUIT Achieve Life Sciences, Inc. | 508,199 | $3.0M | 0.15% | Added +845% |
| KROS Keros Therapeutics, Inc. | 239,194 | $2.7M | 0.13% | Reduced −3% |
| MGNX MacroGenics, Inc. | 1,234,595 | $2.5M | 0.12% | Added +851% |
| STRO Sutro Biopharma, Inc. | 267,067 | $2.4M | 0.12% | Reduced −34% |
| ENGN enGene Therapeutics Inc. | 1,329,986 | $2.4M | 0.12% | Reduced −37% |
| INO Inovio Pharmaceuticals, Inc. | 1,444,165 | $2.3M | 0.12% | Reduced −33% |
| SPRB Spruce Biosciences, Inc. | 51,646 | $2.1M | 0.10% | Reduced −24% |
| TARA Protara Therapeutics, Inc. | 850,512 | $2.0M | 0.10% | Reduced −10% |
| CATX Perspective Therapeutics, Inc. | 2,617,870 | $2.0M | <0.1% | Added +116% |
| RNA Atrium Therapeutics, Inc. | 267,586 | $2.0M | <0.1% | Added +364% |
| HOWL Werewolf Therapeutics, Inc. | 2,023,331 | $1.9M | <0.1% | New |
| LONA LeonaBio, Inc. | 777,100 | $1.9M | <0.1% | Unchanged |
| SPRY ARS Pharmaceuticals, Inc. | 560,999 | $1.8M | <0.1% | Reduced −7% |
| TNGX Tango Therapeutics, Inc. | 77,000 | $1.7M | <0.1% | Added +0% |
| RNTX Rein Therapeutics Inc. | 4,500,000 | $1.7M | <0.1% | Unchanged |
| KRSA Korsana Biosciences, Inc. | 43,574 | $1.7M | <0.1% | New |
| RLMD Relmada Therapeutics, Inc. | 551,918 | $1.6M | <0.1% | Added +22% |
| BSX Boston Scientific Corporation | 36,000 | $1.5M | <0.1% | Added +380% |
| MSLE Satellos Bioscience Inc. | 256,687 | $1.5M | <0.1% | Added +15% |
| PALI Palisade Bio, Inc. | 1,541,747 | $1.5M | <0.1% | Reduced −11% |
| BIOA BioAge Labs, Inc. | 276,000 | $1.3M | <0.1% | New |
| LXRX Lexicon Pharmaceuticals, Inc. | 750,000 | $1.3M | <0.1% | Unchanged |
| SIBN SI-BONE, Inc. | 50,000 | $1.2M | <0.1% | Added +11% |
| TRAX First Tracks Biotherapeutics, Inc. | 27,898 | $1.2M | <0.1% | Reduced −61% |
| ELDN Eledon Pharmaceuticals, Inc. | 652,812 | $1.2M | <0.1% | Added +1% |
| IRTC iRhythm Holdings, Inc. | 12,275 | $1.2M | <0.1% | Added +309% |
| WVE Wave Life Sciences, Inc. | 409,084 | $1.1M | <0.1% | Added +156% |
| LUNG Pulmonx Corporation | 404,497 | $1.1M | <0.1% | Unchanged |
| CRVS Corvus Pharmaceuticals, Inc. | 112,100 | $1.1M | <0.1% | Reduced −4% |
| LEGN Legend Biotech Corporation | 70,000 | $1.1M | <0.1% | New |
| STIP iShares 0-5 Year TIPS Bond ETF | 11,000 | $1.1M | <0.1% | Added +175% |
| NVO Novo Nordisk A/S | 28,000 | $1.1M | <0.1% | Added +4% |
| KOD Kodiak Sciences Inc. | 10,500 | $1.0M | <0.1% | New |
| TECX Tectonic Therapeutic, Inc. | 49,501 | $1.0M | <0.1% | Added +241% |
| NGNE Neurogene Inc. | 43,800 | $1.0M | <0.1% | Added +462% |
| RCKT Rocket Pharmaceuticals, Inc. | 442,500 | $949K | <0.1% | Added +2% |
| GRCE Grace Therapeutics, Inc. | 476,190 | $848K | <0.1% | New |
| BNTX BioNTech SE | 10,300 | $843K | <0.1% | Reduced −3% |
| SGOV iShares 0-3 Month Treasury Bond ETF | 8,000 | $805K | <0.1% | New |
| VCRE Vicore Pharma Holding AB (publ) | 79,900 | $792K | <0.1% | New |
| GILD Gilead Sciences, Inc. | 4,648 | $788K | <0.1% | Unchanged |
| TECH Bio-Techne Corporation | 10,500 | $764K | <0.1% | New |
| IVVD Invivyd, Inc. | 1,666,322 | $758K | <0.1% | Reduced −56% |
| LRMR Larimar Therapeutics, Inc. | 237,735 | $751K | <0.1% | Reduced −13% |
| CHRS Coherus Oncology, Inc. | 1,886,346 | $745K | <0.1% | Added +18,097% |
| EOLS Evolus, Inc. | 100,000 | $717K | <0.1% | Unchanged |
| ARE Alexandria Real Estate Equities, Inc. | 16,900 | $713K | <0.1% | Reduced −13% |
| VERA Vera Therapeutics, Inc. | 26,322 | $695K | <0.1% | Added +44% |
| ERAS Erasca, Inc. | 50,000 | $694K | <0.1% | New |
| ALXO ALX Oncology Holdings Inc. | 625,433 | $688K | <0.1% | Added +17% |
| DRUG Bright Minds Biosciences Inc. | 32,300 | $683K | <0.1% | Added +7% |
| RZLT Rezolute, Inc. | 148,679 | $607K | <0.1% | Added +205% |
| TXMD TherapeuticsMD, Inc. | 342,447 | $603K | <0.1% | Unchanged |
| NTRA Natera, Inc. | 2,147 | $599K | <0.1% | Unchanged |
| CORZ Core Scientific, Inc. | 50,000 | $599K | <0.1% | New |
| EVMN Evommune Inc | 82,350 | $596K | <0.1% | Reduced −21% |
| TRVI Trevi Therapeutics, Inc. | 40,800 | $554K | <0.1% | New |
| IDYA IDEAYA Biosciences, Inc. | 20,000 | $531K | <0.1% | Unchanged |
| NAUT Nautilus Biotechnology, Inc. | 251,926 | $515K | <0.1% | New |
| USFR WisdomTree Floating Rate Treasury Fund | 10,000 | $505K | <0.1% | Unchanged |
| VSTM Verastem, Inc. | 72,800 | $493K | <0.1% | Reduced −4% |
| TNYA Tenaya Therapeutics, Inc. | 1,555,500 | $488K | <0.1% | Unchanged |
| ASMB Assembly Biosciences, Inc. | 21,447 | $481K | <0.1% | Added +5% |
| MNKD MannKind Corporation | 118,209 | $478K | <0.1% | New |
| SPTX Seaport Therapeutics, Inc. | 25,000 | $471K | <0.1% | Reduced −4% |
| GERN Geron Corporation | 505,817 | $464K | <0.1% | Unchanged |
| CRBP Corbus Pharmaceuticals Holdings, Inc. | 195,469 | $461K | <0.1% | Reduced −54% |
| GPCR Structure Therapeutics Inc. | 27,500 | $461K | <0.1% | Added +57% |
| RNAC Cartesian Therapeutics, Inc. | 73,877 | $451K | <0.1% | Reduced −25% |
| IHI iShares U.S. Medical Devices ETF | 7,700 | $434K | <0.1% | Added +57% |
| QTTB Q32 Bio Inc. | 50,000 | $414K | <0.1% | New |
| ARVN Arvinas, Inc. | 57,591 | $390K | <0.1% | Unchanged |
| ABOS Acumen Pharmaceuticals, Inc. | 2,114,334 | $381K | <0.1% | Added +0% |
| KARD Kardigan, Inc. | 30,000 | $381K | <0.1% | New |
| MIRM Mirum Pharmaceuticals, Inc. | 3,900 | $377K | <0.1% | Unchanged |
| MDGL Madrigal Pharmaceuticals, Inc. | 895 | $353K | <0.1% | Unchanged |
| ARTV Artiva Biotherapeutics, Inc. | 86,805 | $338K | <0.1% | Reduced −27% |
| ANTX AN2 Therapeutics, Inc. | 58,808 | $315K | <0.1% | Unchanged |
| MLTX MoonLake Immunotherapeutics | 27,000 | $301K | <0.1% | Unchanged |
| IBIO iBio, Inc. | 375,531 | $300K | <0.1% | Unchanged |
| BABA Alibaba Group Holding Limited | 3,578 | $300K | <0.1% | Unchanged |
| PMN ProMIS Neurosciences, Inc. | 92,850 | $295K | <0.1% | Unchanged |
| KURA Kura Oncology, Inc. | 40,000 | $290K | <0.1% | Unchanged |
| RXST RxSight, Inc. | 60,000 | $279K | <0.1% | Added +20% |
| CNSP CNS Pharmaceuticals, Inc. | 70,000 | $257K | <0.1% | Unchanged |
| ALMS Alumis Inc. | 60,000 | $256K | <0.1% | New |
| JD JD.com, Inc. | 10,000 | $253K | <0.1% | Unchanged |
| IBRX ImmunityBio, Inc. | 40,000 | $252K | <0.1% | New |
| PHAT Phathom Pharmaceuticals, Inc. | 42,900 | $216K | <0.1% | Unchanged |
| CUE Cue Biopharma, Inc. | 43,935 | $195K | <0.1% | Reduced −20% |
| SCYX SCYNEXIS, Inc. | 69,387 | $180K | <0.1% | Added +40% |
| BMEA Biomea Fusion, Inc. | 268,420 | $156K | <0.1% | Added +518% |
| WW WW International, Inc. | 20,100 | $149K | <0.1% | Reduced −6% |
| RXRX Recursion Pharmaceuticals, Inc. | 56,000 | $148K | <0.1% | Added +37% |
| ALT Altimmune, Inc. | 102,823 | $144K | <0.1% | Unchanged |
| OGN Organon & Co. | 10,000 | $139K | <0.1% | Unchanged |
| DERM Journey Medical Corporation | 39,517 | $138K | <0.1% | Unchanged |
| KPRX Kiora Pharmaceuticals, Inc. | 167,941 | $133K | <0.1% | Unchanged |
| TRAW Traws Pharma, Inc. | 597,729 | $132K | <0.1% | Unchanged |
| COYA Coya Therapeutics, Inc. | 40,900 | $124K | <0.1% | Unchanged |
| CNTX Context Therapeutics Inc. | 750,969 | $123K | <0.1% | Unchanged |
| BCAX Bicara Therapeutics Inc. | 13,705 | $123K | <0.1% | Unchanged |
| STIM Neuronetics, Inc. | 100,000 | $120K | <0.1% | Unchanged |
| LABD Direxion Daily S&P Biotech Bear 3X Shares | 13,211 | $110K | <0.1% | New |
| CMPX Compass Therapeutics, Inc. | 119,500 | $87K | <0.1% | Reduced −2% |
| NMRA Neumora Therapeutics, Inc. | 246,000 | $82K | <0.1% | Added +17% |
| KLRS Kalaris Therapeutics, Inc. | 60,000 | $82K | <0.1% | Reduced −40% |
| ACRS Aclaris Therapeutics, Inc. | 22,000 | $77K | <0.1% | New |
| VERU Veru Inc. | 35,000 | $73K | <0.1% | Unchanged |
| NEUP Neuphoria Therapeutics Inc. | 30,000 | $70K | <0.1% | Unchanged |
| LITS Lite Strategy, Inc. | 67,292 | $58K | <0.1% | Unchanged |
| VYGR Voyager Therapeutics, Inc. | 35,000 | $57K | <0.1% | Unchanged |
| CLNN Clene Inc. | 15,000 | $54K | <0.1% | Unchanged |
| ABUS Arbutus Biopharma Corporation | 10,522 | $42K | <0.1% | Reduced −99% |
| CABA Cabaletta Bio, Inc. | 40,000 | $40K | <0.1% | Reduced −20% |
| MIST Milestone Pharmaceuticals Inc. | 100,000 | $39K | <0.1% | Unchanged |
| BBOT BridgeBio Oncology Therapeutics, Inc. | 17,183 | $33K | <0.1% | New |
| KYNB Kyntra Bio, Inc. | 14,341 | $25K | <0.1% | New |
| LGVN Longeveron Inc. | 10,840 | $19K | <0.1% | New |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| OABI OmniAb, Inc. | 947,412 | $4.7M |
| SGMT Sagimet Biosciences Inc. | 437,500 | $4.0M |
| BHF Brighthouse Financial, Inc. | 95,523 | $4.0M |
| FTH Faeth Therapeutics, Inc. | 361,010 | $3.2M |
| PRLD Prelude Therapeutics Incorporated | 900,900 | $3.0M |
| MCK McKesson Corporation | 2,500 | $2.7M |
| ORKA Oruka Therapeutics, Inc. | 20,840 | $2.0M |
| AVTR Avantor, Inc. | 130,000 | $1.9M |
| IOVA Iovance Biotherapeutics, Inc. | 146,090 | $1.1M |
| FWRD Forward Air Corporation | 48,241 | $827K |
| KIDS OrthoPediatrics Corp. | 25,000 | $814K |
| ACAD Acadia Pharmaceuticals Inc. | 38,955 | $692K |
| DYN Dyne Therapeutics, Inc. | 42,821 | $690K |
| SYK Stryker Corporation | 2,000 | $633K |
| MRK Merck & Co., Inc. | 3,140 | $429K |
| BNTC Benitec Biopharma Inc. | 40,000 | $318K |
| PSNL Personalis, Inc. | 15,000 | $217K |
| ANAB AnaptysBio, Inc. | 3,698 | $175K |
| BCYC Bicycle Therapeutics plc | 50,638 | $147K |
| CMMB Chemomab Therapeutics Ltd. | 80,000 | $103K |
| TRDA Entrada Therapeutics, Inc. | 15,500 | $70K |
| VTGN Vistagen Therapeutics, Inc. | 351,141 | $67K |
| GOSS Gossamer Bio, Inc. | 2,657 | $30K |
| QCLS Q/C Technologies, Inc. | 50,000 | $14K |